|
March 29, 2002
The Honorable Paul E. Patton
100 State Capitol
700 Capitol Avenue
Frankfort, KY 40601
Dear Governor Patton:
On behalf of the Biotechnology Industry Organization (BIO), I am writing
to express concern with legislation pending in the Kentucky Senate. House
Bill 138 would prohibit all forms of human cloning. In addition to banning
cloning for human reproductive purposes, by making researchers Class C
felons, this bill will effectively outlaw nuclear transfer technology
for therapeutic purposes.
BIO opposes human reproductive cloning. It is too dangerous technically
and raises far too many ethical and social questions. However, using cloning
technology (somatic cell nuclear transfer) to clone human cells for therapeutic
purposes is considered one of the most promising avenues of research for
developing cures for a wide array of diseases and disabilities.
We concur with recent recommendations by the National Academy of Sciences
(NAS) that the cloning of human beings for reproductive purposes should
be prohibited. However, the report also states that "the scientific
and medical considerations that justify a ban on human reproductive cloning
at this time are not applicable to nuclear transplantation to produce
stem cells. Because of the considerable potential for developing new medical
therapies to treat life-threatening diseases and advancing biomedical
knowledge, the panel supported the conclusion of a previous National Academies'
report-Stem Cells and the Future of Regenerative Medicine-that recommends
that biomedical research using nuclear transplantation to produce stem
cells be permitted." (A copy of this report is available on the NAS
Web site, www.nationalacademies.org.)
The implications of cloning a human being need to be addressed by scientists,
ethicists, religious leaders, health professionals, patients and broader
society. We are concerned that, unless people clearly understand the benefits
and limitations of different scientific techniques, research can be threatened
by well-meaning legislation like House Bill 138.
Thank you for your consideration of our concerns. If you have any questions,
please contact me or Patrick Kelly, director of state government relations,
at (202) 962-9200.
Sincerely,
Carl B. Feldbaum
President |
cc: Kentucky Life Sciences Organization
CBF:pmk
| 
Printer Friendly
